Skip to main content
. 2009 Jan 29;24(Suppl 1):S189–S194. doi: 10.3346/jkms.2009.24.S1.S189

Fig. 1.

Fig. 1

Immunostaining for advanced glycation end products in the peritoneal mesothelial cell. The mesothelial cells of group I (A) and group II (B) show moderate to strong expression. However, the mesothelial cells of group III (C) show weak expression.